Chadi is delighted and honored to host an icon and pioneer in precision medicine and the molecular understanding of cancer as we know it: Ray Kurzrock, MD, FACP, Center Associate Director and Professor at the Medical College of Wisconsin as well as CMO of the WIN consortium.
Nobody knows the history of precision medicine like Ray does. She was doubted when she started, but her resilience and perseverance led to unprecedented progress that she led along with her mentors, mentees, and colleagues.
She details her early appointment to leading the phase I trials at MD Anderson Cancer Center and developing a protocol for matching targeted therapy trials to the right patients, the origins of the term “precision medicine,” resistance to precision medicine and genomics by different stakeholders, how accelerated approvals are better suited for precision medicine versus randomized controlled trials, and a host of other topics in this riveting and spirited dialogue.
We owe much of our current understanding of cancer as a molecularly driven disease to Ray as she had an immeasurable impact on the field.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
